![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
Acquired carbapenemases in Enterobacterales and Pseudomonas aeruginosa |
Thursday 21st January 2021 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]()
|
![]() |
Hospital and community laboratories are requested to refer all isolates of possible carbapenemase-producing Enterobacterales (CPE) and carbapenemase-producing Pseudomonas aeruginosa to ESR for confirmation and further characterisation. CPE surveillance reports are available. The first report covers the 6-year period 2009 (when the first CPE was identified in New Zealand) to 2014. Annual CPE surveillance reports are available for 2015 to 2018. In addition, until the annual surveillance report for the year is available, a cumulative line listing of carbapenemase-producing Enterobacterales and Pseudomonas aeruginosa confirmed during the year, updated at the end of each month, is available as an Excel file. Terms of Reference
|
![]() |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |